Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A50341 | 35428541 | Nutr Metab Cardiovasc Dis | Lipids and diastolic dysfunction: Recent evidence and findings. | 2022 | Details |
| A50359 | 35418240 | Arterioscler Thromb Vasc Biol | Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. | 2022 | Details |
| A50373 | 35413066 | PLoS One | Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease. | 2022 | Details |
| A50375 | 35412485 | Eur J Gastroenterol Hepatol | An elevated FIB-4 score is not associated with cardiovascular events: a longitudinal analysis from 137 842 patients with and without chronic liver disease. | 2022 | Details |
| A50377 | 35412016 | Clin Obes | The impact of health status, diet and lifestyle on non-alcoholic fatty liver disease: Narrative review. | 2022 | Details |
| A50395 | 35406066 | Nutrients | Amino Acid-Related Metabolic Signature in Obese Children and Adolescents. | 2022 | Details |
| A50402 | 35403791 | EMBO Rep | Endothelial-immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease. | 2022 | Details |
| A50404 | 35403438 | Am J Physiol Endocrinol Metab | Loss of low-molecular-weight protein tyrosine phosphatase shows limited improvement in glucose tolerance but causes mild cardiac hypertrophy in mice. | 2022 | Details |
| A50405 | 35403232 | Hepatology | Risk of cardiovascular disease and loss in life expectancy in NAFLD. | 2022 | Details |
| A50408 | 35402530 | Front Cardiovasc Med | Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study. | 2022 | Details |
| A50423 | 35397399 | Eur J Med Chem | Synthesis of heterocyclic ring-fused analogs of HMG499 as novel degraders of HMG-CoA reductase that lower cholesterol. | 2022 | Details |
| A50440 | 35391786 | J Lipids | Age- and Diet-Dependent Changes in Hepatic Lipidomic Profiles of Phospholipids in Male Mice: Age Acceleration in Cyp2b-Null Mice. | 2022 | Details |
| A50445 | 35388643 | Endocrinol Diabetes Metab | Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH. | 2022 | Details |
| A50451 | 35385529 | PLoS One | Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals. | 2022 | Details |
| A50478 | 35370963 | Front Endocrinol (Lausanne) | The Mechanism Underlying the Influence of Indole-3-Propionic Acid: A Relevance to Metabolic Disorders. | 2022 | Details |
| A50496 | 35364761 | J Endocrinol Invest | Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD. | 2022 | Details |
| A50498 | 35364328 | Endocr Pract | Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals. | 2022 | Details |
| A50500 | 35363906 | Hepatology | An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT project. | 2022 | Details |
| A50518 | 35355151 | Clin Rheumatol | Association between circulating cystatin C and hyperuricemia: a cross-sectional study. | 2022 | Details |
| A50523 | 35354619 | BMJ Open | Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014. | 2022 | Details |
| A50530 | 35352460 | Hepatol Res | Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease. | 2022 | Details |
| A50548 | 35345258 | Rev Cardiovasc Med | Cardiovascular events after liver transplantation: MACE hurts. | 2022 | Details |
| A50561 | 35339670 | Clin Gastroenterol Hepatol | Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects. | 2022 | Details |
| A50567 | 35338446 | Diabetes Ther | Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications. | 2022 | Details |
| A50572 | 35334916 | Nutrients | Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50574 | 35334864 | Nutrients | High Compliance to Mediterranean Diet Associates with Lower Platelet Activation and Liver Collagen Deposition in Patients with Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50582 | 35333295 | Alcohol Alcohol | Alcohol Consumption: Medical Implications, the Liver and Beyond. | 2022 | Details |
| A50583 | 35333288 | Adv Nutr | Perspective: Is it Time to Expand Research on 'Nuts' to Include 'Seeds'? Justifications and Key Considerations. | 2022 | Details |
| A50603 | 35328352 | Int J Mol Sci | Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study. | 2022 | Details |
| A50629 | 35321955 | Gut Liver | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease. | 2022 | Details |
| A50641 | 35317977 | Dig Liver Dis | Comment on "Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease". | 2022 | Details |
| A50648 | 35316465 | Curr Diab Rep | Implementation of Cardiometabolic Centers and Training Programs. | 2022 | Details |
| A50649 | 35315107 | Aliment Pharmacol Ther | Editorial: opposite effects of genetic polymorphisms known to induce NAFLD on hepatic and cardiovascular outcomes in Chinese population. | 2022 | Details |
| A50650 | 35315106 | Aliment Pharmacol Ther | Editorial: opposite effects of genetic polymorphisms known to induce NAFLD on hepatic and cardiovascular outcomes in Chinese population-authors' reply. | 2022 | Details |
| A50664 | 35308580 | Curr Infect Dis Rep | Advances in Liver Transplantation for Persons with Human Immunodeficiency Infection. | 2022 | Details |
| A50667 | 35308229 | Front Pharmacol | Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies. | 2022 | Details |
| A50682 | 35304191 | Mol Cell Endocrinol | Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism. | 2022 | Details |
| A50688 | 35302179 | Intern Emerg Med | Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease. | 2022 | Details |
| A50699 | 35295895 | Visc Med | Metabolic Surgery: Paradigm Shift in Metabolic Syndrome/Diabetes Therapy. | 2022 | Details |
| A50709 | 35292328 | Diabetes Res Clin Pract | Associations of NAFLD with circulating ceramides and impaired glycemia. | 2022 | Details |
| A50714 | 35289937 | J Sci Food Agric | Radio frequency as an innovative method to produce low-fat French fries. | 2022 | Details |
| A50734 | 35283365 | J Obes Metab Syndr | Hepatic Fibrosis and Steatosis in Metabolic Syndrome. | 2022 | Details |
| A50738 | 35283187 | Metabolism | Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease. | 2022 | Details |
| A50739 | 35283114 | Gastroenterology | Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50744 | 35280895 | Front Med (Lausanne) | Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness. | 2022 | Details |
| A50764 | 35276001 | J Clin Endocrinol Metab | Endotoxin Biomarkers Are Associated With Adiposity and Cardiometabolic Risk Across 6 Years of Follow-up in Youth. | 2022 | Details |
| A50768 | 35273712 | Am J Transl Res | Multivariable-adjusted trends in mortality due to alcoholic liver disease among adults in the United States, from 1999-2017. | 2022 | Details |
| A50778 | 35269812 | Int J Mol Sci | Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50783 | 35268466 | J Clin Med | The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2022 | Details |
| A50785 | 35268076 | Nutrients | The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence. | 2022 | Details |
| A50788 | 35266164 | Aliment Pharmacol Ther | Review article: role of glucagon-like peptide-1 receptor agonists in non-alcoholic steatohepatitis, obesity and diabetes-what hepatologists need to know. | 2022 | Details |
| A50807 | 35234696 | Chin Med J (Engl) | Therapeutic developments in metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
| A50847 | 34992133 | Gut | Optimising the management of cardiovascular comorbidities in NAFLD patients: it's time to (re-) act! | 2022 | Details |
| A50869 | 34747669 | Angiology | Non-Alcoholic Fatty Pancreas Disease: A Diagnosis of Increasing Importance. | 2021 | Details |
| A50875 | 34675888 | Front Endocrinol (Lausanne) | Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases. | 2021 | Details |
| A50879 | 34619075 | Cell Metab | A glimpse at the metabolic research in China. | 2021 | Details |
| A50910 | 33733940 | Nutr Cancer | Predictors of Sarcopenia in an Obese Asian Population. | 2021 | Details |
| A50947 | 31659265 | Nat Rev Gastroenterol Hepatol | NAFLD and risk of cardiovascular disease. | 2019 | Details |
| A50956 | 35520248 | RSC Adv | Blond and blood juice supplementation in high fat diet fed mice: effect on antioxidant status and DDAH/ADMA pathway. | 2019 | Details |
| A50966 | 35548751 | RSC Adv | Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese mice. | 2018 | Details |
| A51057 | 19574981 | Am J Gastroenterol | NAFLD and cardiovascular risk: direct evidence for the tale of two ages. | 2009 | Details |
| A51059 | 19015652 | Nat Clin Pract Gastroenterol Hepatol | What advice should be given to patients with NAFLD about the consumption of alcohol? | 2008 | Details |
| A51077 | 16025509 | Hepatology | Circulatory dysfunction in NAFLD--which is first, which is last, and what do we do in between? | 2005 | Details |
| A51089 | 35803839 | J Diabetes Complications | Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus. | 2022 | Details |
| A51090 | 35803515 | Int J Surg | Clinical evidence of outcomes following liver transplantation in patients with nonalcoholic steatohepatitis: An updated meta-analysis and systematic review. | 2022 | Details |
| A51105 | 35745205 | Nutrients | Metabolic Impact of MKP-2 Upregulation in Obesity Promotes Insulin Resistance and Fatty Liver Disease. | 2022 | Details |
| A51125 | 35617705 | J Med Food | Partial Replacement of High-Fat Diet with Beef Tallow Attenuates Dyslipidemia and Endoplasmic Reticulum Stress in db/db Mice. | 2022 | Details |
| A51126 | 35614007 | Dig Liver Dis | Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease. | 2022 | Details |
| A51140 | 35512972 | Fertil Steril | Heart health in polycystic ovary syndrome: time to act on the data. | 2022 | Details |
| A51143 | 35504562 | Clin Gastroenterol Hepatol | Nomenclature Dilemma of Metabolic Associated Fatty Liver Disease (MAFLD): Considerable Proportions of MAFLD Are Metabolic Healthy. | 2022 | Details |
| A51150 | 35467861 | J Med Chem | Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions. | 2022 | Details |
| A51159 | 35432002 | Front Physiol | The Cardiovascular and Metabolic Effects of Chronic Hypoxia in Animal Models: A Mini-Review. | 2022 | Details |
| A51168 | 35394181 | Eur Radiol | Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy. | 2022 | Details |
| A51181 | 35331110 | Curr Mol Med | Oxidative damage by 3-nitrotyrosine in young adults with obesity: its implication in chronic and contagious diseases. | 2022 | Details |
| A51186 | 35296424 | Biochim Biophys Acta Mol Cell Biol Lipids | Mechanisms of intestinal triacylglycerol synthesis. | 2022 | Details |
| A51188 | 35285920 | JAMA Netw Open | Association of Low- and No-Calorie Sweetened Beverages as a Replacement for Sugar-Sweetened Beverages With Body Weight and Cardiometabolic Risk: A Systematic Review and Meta-analysis. | 2022 | Details |
| A51296 | 35812273 | Kidney Int Rep | ACLY and CKD: A Mendelian Randomization Analysis. | 2022 | Details |
| A51305 | 35749425 | PLoS Pathog | Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19. | 2022 | Details |
| A51353 | 35372676 | Transplant Direct | The Utility of Noninvasive PET/CT Myocardial Perfusion Imaging in Adult Liver Transplant Candidates. | 2022 | Details |
| A51357 | 35332108 | Aging (Albany NY) | Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment. | 2022 | Details |
| A51361 | 35294954 | PLoS One | Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis. | 2022 | Details |
| A51367 | 34435180 | Matrix Biol Plus | Procollagen C-proteinase enhancer-1 (PCPE-1), a potential biomarker and therapeutic target for fibrosis. | 2021 | Details |
| A51388 | 30623143 | JACC Basic Transl Sci | The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways. | 2018 | Details |
| A51396 | 35830001 | Drugs | Tirzepatide: First Approval. | 2022 | Details |
| A51420 | 35665672 | Transplant Rev (Orlando) | A comprehensive review of coronary artery disease in patients with end-stage liver disease. | 2022 | Details |
| A51429 | 35498015 | Front Cardiovasc Med | The Evolving Story of Multifactorial Chylomicronemia Syndrome. | 2022 | Details |
| A51435 | 35402726 | Clin Exp Hepatol | Impact of left ventricular diastolic dysfunction on liver transplantation outcomes based on the latest American Society of Echocardiography/European Association of Cardiovascular Imaging recommendations. | 2021 | Details |
| A51445 | 35330106 | Life (Basel) | Bone Marrow Mesenchymal Stem Cells and Their Derived Extracellular Vesicles Attenuate Non-Alcoholic Steatohepatitis-Induced Cardiotoxicity via Modulating Cardiac Mechanisms. | 2022 | Details |
| A51500 | 35794109 | Signal Transduct Target Ther | Trends in insulin resistance: insights into mechanisms and therapeutic strategy. | 2022 | Details |
| A51508 | 35741222 | Diagnostics (Basel) | Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease. | 2022 | Details |
| A51516 | 35700885 | Clin Gastroenterol Hepatol | Nomenclature Dilemma of MAFLD Across the Globe: Our Prism to Understand Metabolic Dysfunction and Cardiovascular Risk in MAFLD. | 2022 | Details |
| A51520 | 35668935 | Front Pharmacol | Croton urucurana Baill. Ameliorates Metabolic Associated Fatty Liver Disease in Rats. | 2022 | Details |
| A51521 | 35655263 | Cardiovasc Diabetol | Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex. | 2022 | Details |
| A51528 | 35566616 | J Clin Med | Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk. | 2022 | Details |
| A51534 | 35521833 | J Clin Endocrinol Metab | Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction-associated Fatty Liver Disease. | 2022 | Details |
| A51536 | 35491295 | Trends Endocrinol Metab | SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
| A51539 | 35464261 | Diabetes Metab Syndr Obes | Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study. | 2022 | Details |
| A51540 | 35457118 | Int J Mol Sci | Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). | 2022 | Details |
| A51545 | 35362137 | Aliment Pharmacol Ther | Letter: skipping breakfast is associated with an increased long-term cardiovascular mortality in metabolic dysfunction-associated fatty liver disease (MAFLD) but not MAFLD-free individuals. | 2022 | Details |
| A51546 | 35362128 | Aliment Pharmacol Ther | Letter: skipping breakfast is associated with an increased long-term cardiovascular mortality in metabolic dysfunction-associated fatty liver disease (MAFLD) but not in MAFLD-free individuals. Authors' reply. | 2022 | Details |